Banco Macro Valuation

Is BMA.D undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BMA.D when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: BMA.D ($8.39) is trading above our estimate of fair value ($4.25)

Significantly Below Fair Value: BMA.D is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for BMA.D?

Key metric: As BMA.D is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for BMA.D. This is calculated by dividing BMA.D's market cap by their current earnings.
What is BMA.D's PE Ratio?
PE Ratio12.2x
EarningsAR$471.29b
Market CapAR$5.72t

Price to Earnings Ratio vs Peers

How does BMA.D's PE Ratio compare to its peers?

The above table shows the PE ratio for BMA.D vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.1x
GGAL Grupo Financiero Galicia
11.7x8.4%AR$9.3t
BBAR Banco BBVA Argentina
27.2x22.2%AR$3.7t
BPAT Banco Patagonia
16.8xn/aAR$1.6t
BHIP Banco Hipotecario
12.9xn/aAR$690.9b
BMA.D Banco Macro
12.2x36.8%US$5.7t

Price-To-Earnings vs Peers: BMA.D is good value based on its Price-To-Earnings Ratio (12.2x) compared to the peer average (17.1x).


Price to Earnings Ratio vs Industry

How does BMA.D's PE Ratio compare vs other companies in the South American Banks Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
BMA.D 12.2xIndustry Avg. 8.7xNo. of Companies10PE0612182430+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: BMA.D is expensive based on its Price-To-Earnings Ratio (12.2x) compared to the South American Banks industry average (8.7x).


Price to Earnings Ratio vs Fair Ratio

What is BMA.D's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BMA.D PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio12.2x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BMA.D's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BMA.D forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$8.39
US$12.23
+45.8%
32.7%US$17.90US$7.95n/a5
Nov ’25US$7.80
US$13.04
+67.2%
32.6%US$18.09US$8.03n/a4
Oct ’25US$6.91
US$29.87
+332.3%
115.5%US$98.33US$7.15n/a5
Sep ’25US$5.94
US$11.17
+88.0%
36.0%US$18.88US$7.30n/a5
Aug ’25US$4.75
US$11.21
+136.0%
40.0%US$19.64US$7.21n/a5
Jul ’25US$6.00
US$11.21
+86.8%
40.0%US$19.64US$7.21n/a5
Jun ’25US$6.10
US$10.62
+74.1%
46.6%US$19.98US$6.71n/a5
May ’25n/a
US$6.32
0%
48.6%US$11.64US$2.59n/a5
Apr ’25n/a
US$4.22
0%
43.5%US$7.06US$1.91n/a5
Mar ’25n/a
US$3.52
0%
33.3%US$5.25US$1.92n/a5
Feb ’25n/a
US$3.43
0%
43.6%US$5.40US$1.01n/a5
Jan ’25n/a
US$5.60
0%
50.6%US$9.88US$2.26n/a5
Dec ’24n/a
US$5.64
0%
51.9%US$10.07US$2.31n/a5
Nov ’24n/a
US$5.68
0%
48.3%US$10.35US$2.37US$7.805
Oct ’24n/a
US$4.57
0%
44.2%US$6.90US$1.05US$6.915
Sep ’24n/a
US$4.57
0%
44.2%US$6.90US$1.05US$5.945
Aug ’24US$3.00
US$3.94
+31.3%
67.8%US$6.66US$1.25US$4.754
Jul ’24n/a
US$3.94
0%
67.8%US$6.66US$1.25US$6.004
Jun ’24n/a
US$3.32
0%
70.4%US$7.07US$1.32US$6.104
May ’24n/a
US$3.34
0%
78.7%US$8.18US$1.33n/a5
Apr ’24n/a
US$3.34
0%
78.7%US$8.18US$1.33n/a5
Mar ’24n/a
US$3.49
0%
78.4%US$8.48US$1.37n/a5
Feb ’24n/a
US$3.70
0%
80.0%US$9.08US$1.28n/a5
Jan ’24n/a
US$3.48
0%
89.7%US$9.65US$1.36n/a5
Dec ’23n/a
US$2.80
0%
53.8%US$5.66US$1.47n/a5
Nov ’23n/a
US$2.91
0%
54.3%US$5.90US$1.48n/a5

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies